Gonadorelin: Reference Overview and Reconstitution Notes

Gonadorelin is a man-made peptide (a short chain of amino acids, which are the building blocks of proteins) whose sequence is identical to a natural hormone signal called gonadotropin-releasing hormone (GnRH). It falls under the reproductive and endocrine (hormone-related) peptide category. No gonadorelin product is currently approved and sold in the United States, so it is handled only as a research or compounding compound.

What it is

Gonadorelin is a man-made peptide made up of exactly ten amino acids. Its sequence is identical to GnRH, a natural hormone signal produced by the brain. Because of this, it belongs to the GnRH and releasing-hormone peptide family.

It acts on the pituitary gland (a small gland at the base of the brain that controls many other hormones) as a signal to release other hormones. It is not a sex hormone itself.

Research context and categorization

Gonadorelin is grouped under the reproductive and endocrine category. Endocrine simply means relating to the body's hormone system. It is studied as part of the signaling chain that runs from the brain to the pituitary gland and on to the reproductive organs. When the pituitary receives gonadorelin in short bursts (like timed pulses), it responds by releasing two important hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH), both of which play key roles in reproduction.

Think of gonadorelin as a doorbell. Each time it rings, the pituitary gland answers by sending out LH and FSH.

In the past, it was used as a diagnostic tool to test how well the pituitary gland responds to signals. Versions that delivered it in timed pulses were also studied for certain reproductive conditions linked to low GnRH levels. In current research and compounding discussions, it often comes up in the context of maintaining reproductive signaling and hormone-focused studies.

Any uses beyond those earlier historical indications are investigational. They are not confirmed or approved benefits, and results depend on the specific research context.

Status

Regulatory and Sport Status

• Regulatory status: Research-only and not currently FDA-approved or marketed. No gonadorelin product is presently FDA-approved and commercially available in the United States. An earlier branded diagnostic product (Factrel) was withdrawn from the market. Material today generally comes from compounding pharmacies or research suppliers. It did historically carry FDA-approved uses for diagnostic pituitary testing.
• Sport status: Prohibited under the WADA Prohibited List. WADA stands for World Anti-Doping Agency, the global body that sets anti-doping rules for sport. Gonadorelin and other GnRH agonists (compounds that mimic GnRH) fall under class S2 (peptide hormones, growth factors, related substances, and mimetics). They are prohibited in males because they stimulate testosterone production. In females, GnRH agonists are not prohibited under this provision.

Key point: Gonadorelin is a man-made GnRH match studied for hormone signaling, but it currently has no active FDA-approved commercial products in the U.S. and is WADA-prohibited for male athletes.

Reconstitution notes (general)

Reconstitution means mixing a freeze-dried powder back into liquid. The concentration (how strong the solution is) equals the milligrams of peptide in the vial divided by the millilitres of bacteriostatic water added. Bacteriostatic water is specially prepared water that contains a small preservative to stop bacteria from growing.

For example, a 2 mg vial mixed with 2 mL of bacteriostatic water gives a concentration of 1 mg/mL.

To work out a concentration or fill volume for any vial size, use the calculator at peptide calculator.

Dilution and handling notes (compound-specific)

Reconstitution Strengths

Gonadorelin ships as a fine white lyophilized (freeze-dried) powder. It is mixed with liquid before laboratory use. Common vial sizes are around 2 mg, 5 mg, and 10 mg.

A typical starting point is a 2 mg vial mixed with about 1 to 2 mL of bacteriostatic water, landing the concentration at about 1 to 2 mg/mL. Larger vials are scaled the same way. The amount of water is chosen mainly to give an easy-to-measure draw volume. Gonadorelin dissolves readily in water at these concentrations, so there is no hard solubility limit to worry about.

Mixing Guidelines

Gonadorelin dissolves easily. It does not normally gel, turn cloudy, or form solid bits at standard reconstitution concentrations.

1. Add the water slowly against the inside wall of the vial.
2. Swirl gently in a slow circle rather than shaking. Hard shaking can cause foaming and may stress the peptide.
3. If a little powder remains, let the vial sit at room temperature for a few minutes and swirl again. This usually finishes dissolving it.

A correctly mixed vial should look clear with no visible particles. Persistent cloudiness or floating bits are a sign to discard the vial and not use it. Gonadorelin is also sensitive to light, so keep preparations shielded from light during both handling and storage.

Handling and storage

Storage Guidelines

• Refrigerate the reconstituted vial at 2 to 8 degrees Celsius and keep it away from direct light.
• Wipe the rubber stopper with an alcohol swab before each puncture, and write the mix date on the vial label.
• Follow the general four-week (about 28-day) refrigerated window. Avoid repeatedly freezing and then thawing the vial. Discard anything that turns cloudy, changes color, or develops floating particles.

Related reading

• HCG
• HMG (Menotropins)
• Liraglutide
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is gonadorelin and how does it relate to GnRH?

Gonadorelin is a synthetic peptide whose amino-acid sequence is identical to endogenous GnRH. Applied in short pulses, it signals the pituitary gland to release LH and FSH. It is not a sex hormone itself.

Is gonadorelin FDA-approved or commercially available in the United States?

No. The earlier branded product Factrel was withdrawn from the market. Gonadorelin currently has no active FDA-approved commercial product in the U.S. and is handled only as a research or compounding compound.

How is a lyophilized gonadorelin vial reconstituted for laboratory use?

Add bacteriostatic water to the freeze-dried powder; concentration equals milligrams of peptide divided by millilitres of solvent added. A reconstitution pen or cartridge system allows controlled, low-turbulence injection of the solvent.

What the research community gets wrong about gonadorelin

Gonadorelin comes up a lot in bench notes and supplier listings, and a few mix-ups show up again and again. Here are the ones worth keeping straight when you handle a vial.

• It is not a sex hormone. Gonadorelin is a signaling peptide whose sequence matches GnRH. In the literature it prompts the pituitary to release LH and FSH. It does not act like testosterone or estrogen itself.
• It is not the same as long-acting GnRH agonists. Gonadorelin is the native ten-amino-acid peptide with a very short reported half-life (a few minutes). Modified analogs such as leuprolide are built to last much longer, so notes written for one do not carry over to the other.
• People assume a current FDA-approved human product exists. The active DailyMed entry today is a veterinary (cattle) formulation of Factrel. The older human diagnostic product was withdrawn, so there is no current human reference label to point to.
• Shaking a slow vial harder is a mistake. Gonadorelin goes into solution easily. Hard shaking mainly adds foam and air/liquid interface stress, which can aggregate peptide. A slow swirl and a short rest usually finishes the job.
• Continuous and pulsed delivery are not interchangeable in study design. Bench chatter often treats them as the same, but published work shows continuous GnRH exposure shifts gonadotroph gene expression differently than pulses. That matters when you read or compare research protocols.

From our bench: If you reconstitute gonadorelin, we would like your real numbers on how it holds up. After adding bacteriostatic water and a slow swirl, time how long it takes to reach a clear, particle-free solution, then log the vial's appearance each week across the refrigerated window while keeping it shielded from light. Share your dissolution time, storage temperature, and any day you first noticed cloudiness or particles. We publish observed measurements, not guesses, so send what you actually recorded.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem CID 638793 , Gonadorelin (GnRH/LHRH), compound record
5. FACTREL (gonadorelin hydrochloride) , FDA/DailyMed label
6. Divergent expression patterns of pituitary gonadotropin subunit and GnRH receptor genes to continuous GnRH in vitro and in vivo, Scientific Reports (2019), PMC6934515